DBS Stimulation during sleep for Parkinson's Disease

N/A

Waitlist Available

Led By Gregory Worrell, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, approximately 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve sleep quality in patients with brain implants by sending specific electrical signals during sleep. The idea is that these signals, delivered at the right times, can help these patients sleep better.

Eligible Conditions

Parkinson's Disease
Neurological Disorders
Epilepsy
Overactive Bladder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, approximately 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, approximately 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Participants to Complete Study

Secondary study objectives

Karolinska Sleepiness Scale

Latency to Rapid Eye Movement (REM) Sleep

Latency to Sleep Onset

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Deep Brain Stimulation (DBS) systemExperimental Treatment1 Intervention

Subjects with existing DBS systems implanted for neurological disease (e.g., Parkinson's, pain, epilepsy) will have targeted stimulation patterns during specific stages of sleep using their existing DBS device.

Do I qualify?Apply below to find out